Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Nevitt

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
BMJ Open Diabetes Research & Care|May 19, 2021
Prevalence of peripheral neuropathy in pre-diabetes: a systematic reviewVaro Kirthi, Anugraha Perumbalath, Emily Brown, et al.
Pharmacoeconomics - Open|May 17, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRebecca Bresnahan, Rachel Houten, Janette Greenhalgh, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|September 23, 2022
Screening trials of spinal cord stimulation for neuropathic pain in England-A budget impact analysisRui V Duarte, Rachel Houten, Sarah Nevitt, et al.
Health Technology Assessment (Winchester, England)|September 10, 2024
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysisNigel Fleeman, Rachel Houten, Sarah Nevitt, et al.
Neurosurgery|October 13, 2022
Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results From a Randomized Controlled TrialSam Eldabe, Sarah Nevitt, Sara Griffiths, et al.
Neurosurgery|March 22, 2024
In Reply: Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results from a Randomized Controlled TrialSam Eldabe, Sarah Nevitt, Sara Griffiths, et al.
The American Journal of Tropical Medicine and Hygiene|August 7, 2023
Post-Discharge Risk of Mortality in Children under 5 Years of Age in Western Kenya: A Retrospective Cohort StudyTitus K Kwambai, Simon Kariuki, Menno R Smit, et al.
BMJ Open|April 19, 2020
Seizure First Aid Training For people with Epilepsy (SAFE) frequently attending emergency departments and their significant others: results of a UK multi-centre randomised controlled pilot trialAdam J Noble, Dee Snape, Sarah Nevitt, et al.
Journal of Clinical Epidemiology|October 2, 2020
GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes-Study limitations due to censoring of participants with missing data in intervention studiesMarius Goldkuhle, Ralf Bender, Elie A Akl, et al.
Regional Anesthesia and Pain Medicine|May 29, 2026
Response to: "Methodological limitations and conflicts of interest in spinal cord stimulation research impair trustworthiness"Sam Eldabe, Sarah Nevitt, Corey W Hunter, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
BMJ Open Diabetes Research & Care|May 19, 2021
Prevalence of peripheral neuropathy in pre-diabetes: a systematic reviewVaro Kirthi, Anugraha Perumbalath, Emily Brown, et al.
Pharmacoeconomics - Open|May 17, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRebecca Bresnahan, Rachel Houten, Janette Greenhalgh, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|September 23, 2022
Screening trials of spinal cord stimulation for neuropathic pain in England-A budget impact analysisRui V Duarte, Rachel Houten, Sarah Nevitt, et al.
Health Technology Assessment (Winchester, England)|September 10, 2024
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysisNigel Fleeman, Rachel Houten, Sarah Nevitt, et al.
Neurosurgery|October 13, 2022
Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results From a Randomized Controlled TrialSam Eldabe, Sarah Nevitt, Sara Griffiths, et al.
Neurosurgery|March 22, 2024
In Reply: Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results from a Randomized Controlled TrialSam Eldabe, Sarah Nevitt, Sara Griffiths, et al.
The American Journal of Tropical Medicine and Hygiene|August 7, 2023
Post-Discharge Risk of Mortality in Children under 5 Years of Age in Western Kenya: A Retrospective Cohort StudyTitus K Kwambai, Simon Kariuki, Menno R Smit, et al.
BMJ Open|April 19, 2020
Seizure First Aid Training For people with Epilepsy (SAFE) frequently attending emergency departments and their significant others: results of a UK multi-centre randomised controlled pilot trialAdam J Noble, Dee Snape, Sarah Nevitt, et al.
Journal of Clinical Epidemiology|October 2, 2020
GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes-Study limitations due to censoring of participants with missing data in intervention studiesMarius Goldkuhle, Ralf Bender, Elie A Akl, et al.
Regional Anesthesia and Pain Medicine|May 29, 2026
Response to: "Methodological limitations and conflicts of interest in spinal cord stimulation research impair trustworthiness"Sam Eldabe, Sarah Nevitt, Corey W Hunter, et al.
Pageof 6